We examined the human cytotoxic T-cell repertoire of nine adults to 9 of the 10 proteins of respiratory syncytial (RS) virus. Peripheral blood mononuclear cells from normal adults were stimulated with RS virus in vitro. The resulting polyclonal cultures were tested for lysis of B-lymphoblastoid cell lines infected with recombinant vaccinia viruses expressing each of nine individual RS virus proteins. The use of peripheral blood dendritic cells to present antigen gave more easily reproducible results over a shorter culture period than conventional methods. The six RS virus proteins most strongly recognized were the nucleoprotein N (nine of nine donors with > 10% above background lysis; P = 0.0004), the surface proteins SH (six of nine donors; P = 0.002) and F (five of nine donors; P = 0.008), the matrix proteins M (five of nine donors; P = 0.004) and 22K (three of nine donors; P = 0.01) and the nonstructural protein lb (six of nine donors; P = 0.004). There was no significant recognition of the major surface glycoprotein G (two of nine donors), the internal phosphoprotein P (one of nine donors), or the nonstructural protein lc (one of nine donors). Recognition was major histocompatibility complex class I restricted, but no association between major histocompatibility complex phenotype and protein specificity of T cells was seen. Recognition of F and 22K appeared to be associated with recent infection indicated by increased levels of anti-RS virus immunoglobulin G antibody in serum measured by enzyme-linked immunosorbent assay. Since cytotoxic T-cell recognition of RS virus proteins has been demonstrated to be important in the clearance of virus from infected hosts, the N, M, SH, lb, F, and 22K proteins should be considered potential vaccine components.
Respiratory syncytial (RS) virus is the leading cause of infantile bronchiolitis, the primary condition responsible for hospitalization in this age group. RS virus causes common colds in adults, which may be especially harmful in those with preexisting lung disease (6) . Vaccine trials in the 1960s showed that children immunized with formalin-inactivated RS virus developed strong antibody responses but were not protected against subsequent infection. A large percentage of infected vaccinees developed severe lower respiratory tract disease, and several children died as a result (12, 20, 26, 27) . Antibody levels correlate poorly with protection against infection or severity of disease (45) , while adoptive transfer of primed lymphocytes into immunodeficient mice that are persistently infected with RS virus results in the clearance of infectious virus in the absence of a strong humoral antibody response (11) . Immunoglobulin (Ig)-deficient children are not particularly more susceptible to infection than immunocompetent children, which implies that humoral immune responses play a small or no role in limiting virus infection. Conversely, children with defective cellular immunity are at risk for prolonged RS virus infection, showing that T-cell responses may aid in recovery from disease (18) .
Although class I major histocompatibility complex (MHC)-restricted cytotoxic T cells (CTL) can be beneficial, they may also produce disease. Injection of activated CTL which recognize RS virus can cause hemorrhagic, neutrophilic, and sometimes fatal pneumonitis in RS virus-infected mice (10) . Children with severe RS virus-induced disease * Corresponding author.
have strong delayed-type hypersensitivity reactions and lymphoproliferative responses to RS virus (26, 28, 47) , but attempts to isolate virus-specific T cells from the blood of children have rarely been successful. This is particularly true for children with severe disease (24) . Clearly, more studies are required to determine the types of immune responses against RS virus which are harmful or beneficial to susceptible hosts.
RS virus-induced disease in adults is generally mild and restricted to the upper respiratory tract. If the specific RS virus proteins recognized by adult CTL can be determined, it may be possible to construct a subunit vaccine capable of generating CTL which would protect infants on their first exposure to RS virus infection. Normal healthy adults have all experienced RS virus infection and should exhibit virusspecific T-cell memory. It is possible to generate RS virusspecific class I MHC-restricted CTL in vitro from peripheral blood mononuclear cells (PBMC) in adults (4, 5) . Donor CTL in these studies recognized the N and F proteins but not the G protein. However, this particular result has been shown only for a small number of donors by using a technically difficult approach to generate RS virus-specific effector cells. It has recently been shown that the use of antigen-presenting dendritic cells (DC) is superior to conventional techniques in promoting CTL growth either from unprimed lymphocytes by using peptides or from primed lymphocytes by using whole viral antigen (31) . We Nine rVV containing single RS virus genes, six of which have been described previously, were used in the CTL assays. These were the surface proteins SH (formerly la, rVV-SH [38] ), F (rVV-F [48] ), and G (rVV-G [2] ); the matrix protein 22K (rVV-22K [36] ); and the internal proteins N (rVV-N [29] ) and P (rVV-P [36] (42) . The differences in amino acid sequences result from the lack of the first 23 nucleotides in cDNA clone M166 and the addition of the promoter fragment ATG and the BamHI-SmaI polylinker sequences in the M/VV vector plasmid. A recombinant virus expressing M protein was obtained from VV-infected cells by homologous recombination between VV DNA. Transfected M/VV vector DNA and rVV were isolated by using a temperature shift-thymidine kinase selection procedure described previously (36) .
cDNA clones containing the lc or lb gene were obtained from an RS virus (A2 strain) cDNA library (in plasmid vector pBR322) that has been described previously (15) . To construct rVV transfer vectors that express the lc or lb gene, it was necessary to excise the coding regions of these genes from the cDNA clones with restriction endonucleases to remove the oligo-G/C sequences from the 5' ends of the RS virus gene sequences. The lc gene cDNA clone (a 0.55-kb PstI fragment in pBR322) was subcloned into the PstI site of pGEM1 (Promega) in positive orientation with respect to the T7 promoter. A DNA fragment containing the entire coding sequence of the lc gene was excised from the pGEMl/lc plasmid by digestion with HincII and by partial digestion with RsaI. This lc fragment [bases 25 to 528, including poly(A)] was ligated into the SmaI site of the VV transfer vector pAB191 (2), which lies downstream from the VV 7.5-kDa promoter. VV transfer vectors containing the lc gene in both positive and negative orientations with respect to the VV 7.5-kDa promoter were obtained, and rVV containing the lc gene in either orientation with respect to the VV 7.5-kDa promoter were isolated as previously described (43) (19) was included as a positive control, as was one sample known to be negative. Readings from sera assayed against the control HEp-2 antigen lysate were subtracted from the RS virus antigen lysate. All serum samples and controls were tested at the same time.
RESULTS
Expression of recombinant transcripts containing the lc or lb genes. The expression of RNA transcripts containing the human RS virus lc or lb gene was analyzed by Northern blot hybridization. Hybridization with labelled RNA probes complementary to lc and lb mRNAs showed the predominant monocistronic lc and lb mRNAs (-0.6 kb) and the minor read-through RNA transcripts (-1.1, 1.8, and 2.3 kb) that were synthesized in RS virus-infected cells (Fig. 1A) and have been described in a previous report (14) . lc-or lbspecific mRNA transcripts were identified in cells infected with rW (lc83 and lbll, respectively) that contained the lc or lb gene in positive orientation with respect to the VV 7.5-kDa promoter. The recombinant lc and lb mRNA transcripts synthesized were predominantly monocistronic (-0.89 and 0.8 kb, respectively), although several minor read-through transcripts were determined by Northern blots of identical viral RNA samples by using the 5' and 3' regions of the W thymidine kinase gene as probes (data not shown). In addition, lc-or lb-specific antisense RNA transcripts were identified in cells infected with rW (1c78 and lb31, respectively) that contained the lc or lb gene in negative orientation with respect to the W 7.5-kDa promoter (Fig.  1B) . Predominant monocistronic antisense mRNAs were identified (-0.89 and 0.8 kb), as was the minor read-through Cultures stimulated once with RS virus-infected DC and then incubated for 6, 8, 10, or 14 days gave similar, consistent results with low backgrounds. The longer-term IL-2-and IL-4-restimulated day 29 lines showed less-reproducible results and higher levels of background killing of virally infected targets than the shorter-term lines with no added ILs. For convenience, the human CTL cultures incubated for 8 days without IL-2 or IL-4 were used for standard cytotoxicity assays. Spontaneous release of chromium ranged from 5 to 25% of maximum release, and variation between replicates was <10%. The results of a typical cytotoxicity assay to examine human donor CTL recognition of individual RS virus proteins are shown in Fig. 2 . CTL from donor PT lysed target cells expressing the F, SH, N, M, 22K, and lb proteins but did not lyse target cells expressing the P, G, or lc protein.
To test virus specificity of the assay, effector cells were stimulated with influenza virus or RS virus and tested for the ability to lyse target cells expressing influenza virus or RS virus. Effector cells stimulated with influenza virus did not kill (<10%) target cells infected with either whole RS virus or any of the rVV constructs but did lyse targets infected with influenza virus. Conversely, effector cells stimulated with RS virus did not lyse influenza virus-infected targets (results not shown).
To test whether CTL recognition of individual RS virus proteins was MHC restricted, the ability of donor CTL to recognize RS virus proteins presented by target cells expressing different MHC antigens was assayed. Effector cells from donor MM did not lyse MHC-mismatched target cells (from donor NP) that expressed all 10 of the RS virus proteins or that expressed any of the individual rVV-RS virus proteins. A representative part of this experiment is given in Fig. 3 , showing no lysis of mismatched target cells infected with whole RS virus or rVV-N or rVV-lc. To test whether killing of virus infected targets was MHC class I (HLA-A, -B, or -C)-or MHC class II (HLA-DR or -DQ)-restricted, target cells were incubated prior to the cytotoxicity assay with anti-class I monoclonal antibody W6/32 (37) or anti-class II monoclonal antibody CD41 C6 (41) or irrelevant anti-A3 monoclonal antibody GAP-A3 (7), used with non-HLA-A3 targets. Lysis was inhibited only by the anticlass I monoclonal antibody, as shown in Fig. 4 , suggesting that CTL recognition of RS virus-infected targets is restricted by MHC class I.
Recognition of specific RS virus proteins by CTL from nine human donors. A survey of the pattern of recognition of 9 of the 10 individual RS virus proteins by CTL from nine different human donors was obtained. The individual RS virus proteins recognized varied among donors (Fig. 5) , but those observed most often were the N (nine of nine donors with > 10% above background lysis; P = 0.0004), the surface proteins SH (six of nine donors; P = 0.002) and F (five of nine donors; P = 0.008), the matrix proteins M (five of nine donors; P = 0.004) and 22K (three of nine donors; P = 0.01), and the nonstructural protein lb (six of nine donors; P = 0.004). There was no significant recognition of the major surface glycoprotein G (two of nine donors; P = 0.2), the internal phosphoprotein P (one of nine donors; P = 0.7), or the nonstructural protein lc (one of nine donors; P = 0.6). Levels of antibody specific for RS virus in serum were examined by ELISA to observe any correlation between the presence of RS virus-specific antibody levels and the pattern of protein recognition by the CTL. All donors exhibited levels of anti-RS virus IgG antibody in serum above the negative control. Seven of nine donors exhibited significant levels of anti-RS virus IgA in serum. Only one donor (JL) exhibited a higher level of IgM in serum against RS virus, a result indicative of recent RS virus-exposure. No donor or control sera showed any virus-specific levels of IgE in serum ( Table 1) .
The class I and class II MHC phenotypes of the nine donors were determined to observe whether patterns of individual RS virus proteins recognized by the donor could be related to tissue type. We found no correlation between individual proteins recognized by donors with any specific phenotype.
DISCUSSION
There is considerable evidence that MHC-restricted CTL can protect against viral disease and aid in the clearance of virus from infected hosts. In mice infected with influenza A virus, virus-specific CTL are generated before the production of antibody (49) , specific CTL are responsible for clearing virus from the lungs (32) , and transfer of nucleoprotein-specific CTL can be protective in vivo (44) . CTL can mediate rejection of murine leukemia retrovirus-induced tumors (17) . In humans, virus-specific CTL may be important in the recovery from various viral infections. Human immunodeficiency virus type 1-specific T cells can kill recombinant human immunodeficiency virus-infected autologous B-LCLs (46) or naturally infected macrophages (39) in vitro. One study monitored 43 of 58 patients receiving bone marrow transplants who developed cytomegalovirus infection. Only those patients producing virus-specific CTL survived (40) . A study of 63 influenza A virus-inoculated volunteers showed that those developing virus-specific CTL effectively cleared virus (33) .
The data presented here represent the most complete human study for RS virus cytotoxicity, with the nine available rVV, from donors of diverse phenotype, tested. Of the 10 RS virus proteins, only the putative RNA polymerase protein L was excluded, because of the lack of a recombinant virus expressing this protein. The pattern of recognition by individual donors can be compared with that reported by Gotch et al. (21) , who examined CTL recognition by six individuals of influenza A virus proteins expressed by rVV. In that study, as in this, all donors showed killing of some, but not all, of the rVV-infected targets. Levels of killing of virally infected targets varied among individuals. Some showed strong killing of many targets, while other donors recognized fewer proteins and to a lesser extent. All of the RS virus proteins were recognized by at least one of our nine donors, but certain proteins, particularly the nucleoprotein, were recognized by most or all individuals.
Although recombinant lc and lb mRNA transcripts were identified successfully, the lc and lb protein products have J. VIROL. been difficult to detect for several reasons: (i) the lc and lb genes code for small proteins (14 and 11 kDa, respectively) that are turned over rapidly in infected cells (22) , (ii) conventional antisera raised against RS virus do not contain antibodies which can detect the lc or lb protein, and (iii) attempts to generate specific antibodies against lc or lb by using synthetic peptides have been unsuccessful. However, it has previously been shown that CTL responsiveness to proteins synthesized by rVV is a highly sensitive means of demonstrating protein expression. Therefore, the results presented here showing recognition of rVV-lc and rVV-lb provide the first evidence for the expression of these proteins from the vectors.
The recognition of the nucleoprotein N and the surface protein F has been reported previously for humans (5) and is similar to the situation for influenza A virus, in which NP is the major target for human CTL recognition (34) . The recognition of the matrix proteins M and 22K, nonstructural protein lb, and the surface protein SH has not previously been noted. G was recognized by only two of nine donors in our study, implying that although strongly recognized by certain individuals, on a population basis this protein is not strongly recognized. This helps to confirm partially the previous finding that G was not recognized by the two individuals tested (5) . It (36) . In this study, the 22K protein was recognized by three donors, two of whom exhibited no 22K protein recognition during previous analyses. However, these tests had been carried out during the summer months, when there was little RS virus infection in the community. ELISA performed at the same time showed little anti-RS virus IgG, IgM, or IgA in these donors, but when tests were repeated during the winter and spring months, during and after the RS virus season, increased levels of virus-specific anti-IgG were noted along with recognition of F and 22K in donors PO and PT. This implies that CTL recognition of 22K may be short lived in humans, which is similar to the situation found in mice (13) . The third donor recognizing the 22K protein, donor FR, was accidentally self inoculated with the rVV-22K and rVV-G while scarifying mice (35 and itching in the thumb. Serum samples showed little anti-RS virus antibody of any isotype and showed no increase during the weeks after vaccination. Unfortunately, no cytotoxicity assays were carried out prior to the accident, so we are unable to determine the previous immune status. The lack of recognition of the 22K protein by many of our other donors suggests that the inoculation might have been responsible for inducing CTL against the 22K protein, indicating that rVV might be used to induce antiviral CTL even in previously vaccinated individuals. This partially confirms results of a trial using rVV expressing human immunodeficiency virus envelope glycoprotein (16) . In this phase 1 clinical trial, 13 of 16 VV-exposed subjects developed transient, specific T-cell responses. VV-naive individuals developed strong T-cell responses which were detectable for more than 1 year. This would clearly be the ideal situation in infants, if one vaccination could provide specific protection to take the infant through the period during which RS virus infection is most severe.
All donors had anti-RS virus IgG antibody in serum, confirming past exposure, but only one (donor JL) showed any IgM, suggesting that this was the only donor with recent acute infection. Donor JL had strong responses to F, SH, N, In conclusion, we have shown that six proteins of RS virus are strong targets for class I-restricted cytotoxic T-cell recognition: the surface SH and F, the matrix M and 22K, the internal N, and the nonstructural lb proteins. Recognition of F and 22K proteins may be related to recent exposure, but there was no correlation between proteins recognized and MHC class I or II phenotype.
